Return to More Current References
Older References
-
- Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
- Pokharel HP, Hacker NF, Andrews L.
- Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):633-638. doi: 10.1111/ajo.12504. Epub 2016 Aug 17.
- PMID: 27530527
- PubMed abstract
- Source abstract
-
- Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.
- Vergote I, Banerjee S, Gerdes AM, van Asperen C, Marth C, Vaz F, Ray-Coquard I, Stoppa-Lyonnet D, Gonzalez-Martin A, Sehouli J, Colombo N.
- Eur J Cancer. 2016 Dec;69:127-134. doi: 10.1016/j.ejca.2016.10.006. Epub 2016 Nov 4.
- PMID: 27821315
- PubMed abstract
- Source abstract
-
- Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.
- Weinberger V, Bednarikova M, Cibula D, Zikan M.
- Expert Rev Anticancer Ther. 2016 Dec;16(12):1311-1321. Epub 2016 Oct 22.
- PMID: 27732120
- PubMed abstract
- Source abstract
-
- Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.
- D'Andrea E, Marzuillo C, De Vito C, Di Marco M, Pitini E, Vacchio MR, Villari P.
- Genet Med. 2016 Dec;18(12):1171-1180. doi: 10.1038/gim.2016.29. Epub 2016 Apr 14.
- PMID: 27906166
- PubMed abstract
- Source abstract
- Systematic Review
- Free Full Text
-
- Population Frequency of Germline BRCA1/2 Mutations.
- Maxwell KN, Domchek SM, Nathanson KL, Robson ME.
- J Clin Oncol. 2016 Dec;34(34):4183-4185. Epub 2016 Oct 31.
- PMID: 27551127
- PubMed abstract
- Source abstract
- Letter
- Free Full Text
-
- When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.
- Meiser B, Quinn VF, Gleeson M, Kirk J, Tucker KM, Rahman B, Saunders C, Watts KJ, Peate M, Geelhoed E, Barlow-Stewart K, Field M, Harris M, Antill YC, Mitchell G.
- Eur J Hum Genet. 2016 Nov;24(11):1517-1523. doi: 10.1038/ejhg.2016.69. Epub 2016 Jun 22.
- PMID: 27329735
- PubMed abstract
- Source abstract
-
- Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
- Ring KL, Bruegl AS, Allen BA, Elkin EP, Singh N, Hartman AR, Daniels MS, Broaddus RR.
- Mod Pathol. 2016 Nov;29(11):1381-1389. doi: 10.1038/modpathol.2016.135. Epub 2016 Jul 22.
- PMID: 27443514
- PubMed abstract
- Source abstract
-
- Genetic Tests That Make a Difference After a Breast Cancer Diagnosis.
- Marisa C. Weiss
- U.S. News and World Report. Health Care. Oct. 24, 2016.
- Press article
- Free Full Text
-
- Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
- Moreno L, Linossi C, Esteban I, Gadea N, Carrasco E, Bonache S, Gutiérrez-Enríquez S, Cruz C, Díez O, Balmaña J.
- Clin Transl Oncol. 2016 Oct;18(10):981-7. doi: 10.1007/s12094-015-1470-0. Epub 2016 Jan 7.
- PMID: 26742938
- PubMed abstract
- Source abstract
-
- Young premenopausal women with breast cancer, especially estrogen receptor negative, are at significantly increased risk for subsequent ovarian cancer.
- Lehrer S, Rheinstein PH, Green S, Rosenzweig KE.
- Discov Med. 2016 Oct;22(121):209-213.
- PMID: 27875672
- PubMed abstract
-
- Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
- Sabatier R, Lavit E, Moretta J, Lambaudie E, Noguchi T, Eisinger F, Cherau E, Provansal M, Livon D, Rabayrol L, Popovici C, Charaffe-Jauffret E, Sobol H, Viens P.
- Fam Cancer. 2016 Oct;15(4):497-506. doi: 10.1007/s10689-016-9873-9.
-
- Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma.
- Watson CH, Ulm M, Blackburn P, Smiley L, Reed M, Covington R, Bokovitz L, Tillmanns T.
- Gynecol Oncol. 2016 Oct;143(1):109-12. doi: 10.1016/j.ygyno.2016.07.094. Epub 2016 Jul 12.
- PMID: 27416795
- PubMed abstract
- Source abstract
-
- New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
- Plaskocinska I, Shipman H, Drummond J, Thompson E, Buchanan V, Newcombe B, Hodgkin C, Barter E, Ridley P, Ng R, Miller S, Dann A, Licence V, Webb H, Tan LT, Daly M, Ayers S, Rufford B, Earl H, Parkinson C, Duncan T, Jimenez-Linan M, Sagoo GS, Abbs S, Hulbert-Williams N, Pharoah P, Crawford R, Brenton JD, Tischkowitz M.
- J Med Genet. 2016 Oct;53(10):655-61. doi: 10.1136/jmedgenet-2016-103902. Epub 2016 May 12.
- PMID: 27208206
- PubMed abstract
- Source abstract
-
- Genetic predisposition in gynecologic cancers.
- Daniels MS, Lu KH.
- Semin Oncol. 2016 Oct;43(5):543-547. doi: 10.1053/j.seminoncol.2016.08.005. Epub 2016 Sep 20.
- PMID: 27899185
- PubMed abstract
- Source abstract
-
- Familial prostate cancer.
- Giri VN, Beebe-Dimmer JL.
- Semin Oncol. 2016 Oct;43(5):560-565. doi: 10.1053/j.seminoncol.2016.08.001. Epub 2016 Aug 18.
- PMID: 27899188
- PubMed abstract
- Source abstract
-
- Consensus Guideline on Hereditary Genetic Testing for Patients With and Without Breast Cancer
- ASBS Research committee
- The American Society of Breast Surgeons. www.breastsurgeons.org. 2016 Sep 13.
- Practice Guideline
- Free Full Text (PDF)
Comments on NSGC Discussion Forum Cancer SIG
Subject: American Society of Breast Surgeons Consenus Guidelines on Genetic Testing
Subject: American Society of Breast Surgeons Consenus Guidelines on Genetic Testing
-
- Finding all BRCA pathogenic mutation carriers: best practice models.
- Hoogerbrugge N, Jongmans MC.
- Eur J Hum Genet. 2016 Sep;24 Suppl 1:S19-26. doi: 10.1038/ejhg.2016.95.
- PMID: 27514840
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.
- Pinto C, Bella MA, Capoluongo E, Carrera P, Clemente C, Colombo N, Cortesi L, De Rosa G, Fenizia F, Genuardi M, Gori S, Guarneri V, Marchetti A, Marchetti P, Normanno N, Pasini B, Pignata S, Radice P, Ricevuto E, Russo A, Tagliaferri P, Tassone P, Truini M, Varesco L.
- Future Oncol. 2016 Sep;12(18):2071-5. doi: 10.2217/fon-2016-0189. Epub 2016 May 31.
- PMID: 27241581
- PubMed abstract
- Source abstract
- Commentary
- Free Full Text
-
- Next-Generation Sequencing: Role in Gynecologic Cancers.
- Evans T, Matulonis U.
- J Natl Compr Canc Netw. 2016 Sep;14(9):1165-73.
- PMID: 27587626
- PubMed abstract
- Source abstract
-
- All women with ovarian cancer should be offered genetic testing – so why aren’t they?
- Emma Smith
- Science Blog. Cancer Research UK. 2016 Aug 17.
- Blog post
- Free Full Text
-
- Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
- Stuckey A, Febbraro T, Laprise J, Wilbur JS, Lopes V, Robison K.
- Am J Clin Oncol. 2016 Aug;39(4):363-7. doi: 10.1097/COC.0000000000000073.
- PMID: 24710121
- PubMed abstract
- Source abstract
-
- Molecular Testing in Breast Cancer: A Guide to Current Practices.
- Hagemann IS.
- Arch Pathol Lab Med. 2016 Aug;140(8):815-24. doi: 10.5858/arpa.2016-0051-RA.
- PMID: 27472240
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.
- Donenberg T, Ahmed H, Royer R, Zhang S, Narod SA, George S, Akbari MR, Ali J, Hurley J.
- Breast Cancer Res Treat. 2016 Aug;159(1):131-8. doi: 10.1007/s10549-016-3870-4. Epub 2016 Jul 28.
- PMID: 27469594
- PubMed abstract
-
- Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
- George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, Cloke V, Slade I, Kemp Z, Gore M, Strydom A, Banerjee S, Hanson H, Rahman N.
- Sci Rep. 2016 Jul 13;6:29506. doi: 10.1038/srep29506.
- PMID: 27406733
- PubMed abstract
Comments on NSGC Discussion Forum Cancer SIG
News:
Streamlined genetic testing pathway is developed for women with ovarian cancer.
- PMID: 27418655
- PubMed abstract
- Source abstract
Press: Simplified the Process. (GenomeWeb)
Press: All women with ovarian cancer should be offered genetic testing – so why aren’t they? (Science Blog)
-
- Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases.
- Magdalena K, Monika Z, Adam G, Magdalena R, Marzena L, Wojciech B, Janusz L, Bartosz W.
- Cancer Med. 2016 Jul;5(7):1640-6. doi: 10.1002/cam4.748. Epub 2016 May 11.
- PMID: 27167707
- PubMed abstract
- Source abstract
-
- Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
- Arts-de Jong M, de Bock GH, van Asperen CJ, Mourits MJ, de Hullu JA, Kets CM.
- Eur J Cancer. 2016 Jul;61:137-45. doi: 10.1016/j.ejca.2016.03.009. Epub 2016 May 19.
- PMID: 27209246
- PubMed abstract
- Source abstract
-
- The Unbearably Slow Adoption of Genetic Cancer Tests
- [No author given]
- The Atlantic. 2016 Jul.
- Press article
- Free Full Text
Comments on NSGC Discussion Forum Cancer SIG
-
- The integration of BRCA testing into oncology clinics.
- Percival N, George A, Gyertson J, Hamill M, Fernandes A, Davies E, Rahman N, Banerjee S.
- Br J Nurs. 2016 Jun 23;25(12):690-4. doi: 10.12968/bjon.2016.25.12.690.
- PMID: 27345073
- PubMed abstract
- Source abstract
-
- BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
- Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges VF, Larsen B, Garber JE, Partridge AH.
- JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.
- PMID: 26867710
- PubMed abstract
- Source abstract
Editorial
Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer.
- PMID: 26869327
- PubMed abstract
- Source abstract
Press: BRCA Mutation Testing Increasing in Younger Women (Medscape Oncology)
Press: More than 'Angelina Jolie Effect': BRCA tests spike among breast cancer patients. (Fred Hutch News Service)
Press: More Young Women With Breast Cancer Are Undergoing Genetic Testing, Study Finds. (GenomeWeb)
-
- BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
- Høberg-Vetti H, Bjorvatn C, Fiane BE, Aas T, Woie K, Espelid H, Rusken T, Eikesdal HP, Listøl W, Haavind MT, Knappskog PM, Haukanes BI, Steen VM, Hoogerbrugge N.
- Eur J Hum Genet. 2016 Jun;24(6):881-8. doi: 10.1038/ejhg.2015.196. Epub 2015 Sep 9.
- PMID: 26350514
- PubMed abstract
- Source abstract
-
- The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
- Witkowski L, Goudie C, Ramos P, Boshari T, Brunet JS, Karnezis AN, Longy M, Knost JA, Saloustros E, McCluggage WG, Stewart CJ, Hendricks WP, Cunliffe H, Huntsman DG, Pautier P, Levine DA, Trent JM, Berchuck A, Hasselblatt M, Foulkes WD.
- Gynecol Oncol. 2016 Jun;141(3):454-60. doi: 10.1016/j.ygyno.2016.03.013. Epub 2016 Mar 19.
- PMID: 26975901
- PubMed abstract
- Source abstract
-
- Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
- Cohen PA, Nichols CB, Schofield L, Van Der Werf S, Pachter N.
- Int J Gynecol Cancer. 2016 Jun;26(5):892-7. doi: 10.1097/IGC.0000000000000689.
- PMID: 27051053
- PubMed abstract
- Source abstract
-
- Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
- Nakonechny QB, Gilks CB.
- Surg Pathol Clin. 2016 Jun;9(2):189-99. doi: 10.1016/j.path.2016.01.003. Epub 2016 Apr 11.
- PMID: 27241103
- PubMed abstract
- Source abstract
-
- Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation.
- Andrade KC, Santiago KM, Fortes FP, Mambelli LI, Nóbrega AF, Achatz MI.
- Genet Mol Biol. 2016 May 24;39(2):199-202. doi: 10.1590/1678-4685-GMB-2014-0343.
- PMID: 27223487
- PubMed abstract
- Source abstract
-
- Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
- Karakasis K, Burnier JV, Bowering V, Oza AM, Lheureux S.
- Front Oncol. 2016 May 11;6:119. doi: 10.3389/fonc.2016.00119. eCollection 2016.
- PMID: 27242959
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
- González-Rivera M, Lobo M, López-Tarruella S, Jerez Y, Del Monte-Millán M, Massarrah T, Ramos-Medina R, Ocaña I, Picornell A, Garzón SS, Pérez-Carbornero L, García-Saenz JA, Gómez H, Moreno F, Márquez-Rodas I, Fuentes H, Martin M.
- Breast Cancer Res Treat. 2016 Apr;156(3):507-15. doi: 10.1007/s10549-016-3792-1. Epub 2016 Apr 15.
- PMID: 27083178
- PubMed abstract
- Source abstract
-
- BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
- Unni SK, Schauerhamer MB, Deka R, Tyczynski JE, Fernandes AW, Stevens V, Brixner DI, Stenehjem DD.
- J Ovarian Res. 2016 Mar 22;9(1):18. doi: 10.1186/s13048-016-0227-x.
- PMID: 27004793
- PubMed abstract
-
- Mutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer.
- Zorrieh Zahra A, Kadkhoda S, Behjati F, Aghakhani Moghaddam F, Badiei A, Sirati F, Afshin Alavi H, Atri M, Omranipour R, Keyhani E.
- Int J Mol Cell Med. 2016 Spring;5(2):114-22. Epub 2016 May 9.
- PMID: 27478808
- PubMed abstract
- Source abstract
-
- Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.
- Chay WY, McCluggage WG, Lee CH, Köbel M, Irving J, Millar J, Gilks CB, Tinker AV.
- Int J Gynecol Cancer. 2016 Mar;26(3):431-6. doi: 10.1097/IGC.0000000000000639.
- PMID: 26807643
- PubMed abstract
- Source abstract
-
- Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.
- Ruddy KJ, Risendal BC, Garber JE, Partridge AH.
- J Clin Oncol. 2016 Feb 20;34(6):539-41. doi: 10.1200/JCO.2015.63.5375. Epub 2015 Dec 28.
- PMID: 26712228
- PubMed abstract
- Editorial / Commentary
- Free Full Text
-
- A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project.
- La Verde N, Corsi F, Moretti A, Peissel B, Dalu D, Girelli S, Fasola C, Gambaro A, Roversi G, Azzollini J, Radice P, Pensotti V, Farina G, Manoukian S.
- Tumori. 2016 Feb 4;102(1):45-50. doi: 10.5301/tj.5000407. Epub 2015 Sep 10.
- PMID: 26357973
- PubMed abstract
-
- Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
- Eccles DM, Balmaña J, Clune J, Ehlken B, Gohlke A, Hirst C, Potter D, Schroeder C, Tyczynski JE, Gomez Garcia EB.
- Adv Ther. 2016 Feb;33(2):129-50. doi: 10.1007/s12325-016-0281-1. Epub 2016 Jan 25.
- PMID: 26809252
- PubMed abstract
- Source abstract
-
- Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.
- Wevers MR, Ausems MG, Verhoef S, Bleiker EM, Hahn DE, Brouwer T, Hogervorst FB, van der Luijt RB, van Dalen T, Theunissen EB, van Ooijen B, de Roos MA, Borgstein PJ, Vrouenraets BC, Vriens E, Bouma WH, Rijna H, Vente JP, Kieffer JM, Valdimarsdottir HB, Rutgers EJ, Witkamp AJ, Aaronson NK.
- Genet Med. 2016 Feb;18(2):137-144. doi: 10.1038/gim.2015.50. Epub 2015 Apr 23.
- PMID: 25905441
- PubMed abstract
- Source abstract
-
- Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis.
- Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, Hall P, Czene K.
- J Clin Oncol. 2016 Jan 20;34(3):251-8. doi: 10.1200/JCO.2015.63.0624. Epub 2015 Nov 30.
- PMID: 26628467
- PubMed abstract
- Source abstract
-
- Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.
- Ngeow J, Eng C.
- NPJ Genom Med. 2016 Jan 13;1:15006. doi: 10.1038/npjgenmed.2015.6. eCollection 2016.
- PMID: 29263804
- PubMed abstract
- Editorial
- Free PMC article
- Free Full Text
-
- Genetic screening for gynecological cancer: where are we heading?
- Manchanda R, Jacobs I.
- Future Oncol. 2016 Jan;12(2):207-20. doi: 10.2217/fon.15.278. Epub 2015 Dec 7.
- PMID: 26638726
- PubMed abstract
- Source abstract
-
- Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
- Lheureux S, Karakasis K, Harter P, Scott C, Bacon M, Bryce J, Le Fur N, Pujade-Lauraine E, Oza AM.
- Gynecol Oncol. 2016 Jan;140(1):90-94. doi: 10.1016/j.ygyno.2015.10.010. Epub 2015 Oct 22.
- PMID: 26475959
- PubMed abstract
- Source abstract
-
- BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.
- Mundhofir FE, Wulandari CE, Prajoko YW, Winarni TI.
- Asian Pac J Cancer Prev. 2016;17(3):1539-46.
- PMID: 27039803
- PubMed abstract
- Source abstract
-
- UK BRCA mutation testing in patients with ovarian cancer.
- George A.
- Br J Cancer. 2015 Dec 15;113(S1):S17-S21. doi: 10.1038/bjc.2015.396.
- PMID: 26669451
- PubMed abstract
- Source abstract
-
- Individualiserad behandling vid ovarialcancer kan bli möjlig.
- Kjölhede P, Dahm-Kähler P, Tholander B, Åvall Lundqvist E.
- Lakartidningen. 2015 Dec 8;112. pii: DLUF.
- PMID: 26646960
- PubMed abstract
- Review, [Article in Swedish]
- Free Full Text
-
- [Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome].
- Foretová L, Macháčková E, Palácová M, Navrátilová M, Svoboda M, Petráková K.
- Klin Onkol. 2015 Winter;29 Suppl 1:9-13.
- PMID: 26691937
- PubMed abstract
- Source abstract
-
- Referrals to Genetic Counseling in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, an Institutional Review.
- Jenny Backman, Zenas Chang, Sara Carroll, M. Heather Einstein.
- Gynecologic Oncology. 2015 Dec;139(3):586. 2015 NEAGO ABSTRACTS. doi: 10.1016/j.ygyno.2015.09.029.
-
- Passage of Medicare mandate fails to shorten time to BRCA testing in ovarian cancer patients.
- Olga T. Filippova, Paul J. Feustel, Lisa M. Armao, Joyce N. Barlin, Timothy J. McElrath, Patrick F. Timmins, Daniel C. Kredentser, Heidi E. Godoy.
- Gynecologic Oncology. 2015 Dec;139(3):594. 2015 NEAGO ABSTRACTS. doi: 10.1016/j.ygyno.2015.09.053.
-
- Ovarian cancer study opens door to personalised medicine.
- Rebecca Burbidge.
- PHG Foundation. 2015 Nov 11.
- News
- Free Full Text
-
- Ovarian cancer study paves the way for personalised medicine.
- [No author given]
- Cambridge Network. 2015 Nov 11.
- News
- Free Full Text
-
- Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation: A Uk Health Service Perspective.
- Eccleston A, Bentley A, Dyer M, Vereecken W, George A, Rahman .
- Value Health. 2015 Nov;18(7):A361. doi: 10.1016/j.jval.2015.09.697. Epub 2015 Oct 20.
- PMID: 26532039
- PubMed abstract
- Source abstract
-
- Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.
- Katz SJ, Kurian AW, Morrow M.
- JAMA. 2015 Sep 8;314(10):997-998. doi: 10.1001/jama.2015.8088.
- PMID: 26203642
- PubMed abstract
- Source abstract
-
- BRACAnalysis CDx as a companion diagnostic tool for Lynparza.
- Gunderson CC, Moore KN.
- Expert Rev Mol Diagn. 2015 Sep;15(9):1111-6. doi: 10.1586/14737159.2015.1078238. Epub 2015 Aug 13.
- PMID: 26292709
- PubMed abstract
- Source abstract
-
- The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance.
- Varga E, Chao EC, Yeager ND.
- Fam Cancer. 2015 Sep;14(3):481-5. doi: 10.1007/s10689-015-9790-3.
- PMID: 25712765
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship.
- Jernigan AM, Mahdi H, Rose PG.
- Int J Gynecol Cancer. 2015 Sep;25(7):1232-8. doi: 10.1097/IGC.0000000000000489.
- PMID: 26067864
- PubMed abstract
- Source abstract
-
- AGO Austria recommendations for genetic testing of patients with ovarian cancer.
- Marth C, Hubalek M, Petru E, Polterauer S, Reinthaller A, Schauer C, Scholl-Firon T, Singer CF, Zschocke J, Zeimet AG.
- Wien Klin Wochenschr. 2015 Aug;127(15-16):652-4. doi: 10.1007/s00508-015-0814-7.
- PMID: 26109557
- PubMed abstract
-
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
- Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, Borowsky ME, Gibb RK.
- Cancer. 2015 Jul 1;121(13):2108-20. doi: 10.1002/cncr.29321. Epub 2015 Mar 27.
- PMID: 25820366
- PubMed abstract
- Source abstract
- Review
- Free Full Text
Commentary
Ovarian cancer prevention: Time for primetime?
- PMID: 25820436
- PubMed abstract
- Free article
-
- Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.
- Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek CJ, Ueda S, Collisson EA, Taylor BS.
- J Natl Compr Canc Netw. 2015 Jul;13(7):835-45.
- PMID: 26150578
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
- Ricci MT, Sciallero S, Mammoliti S, Gismondi V, Franiuk M, Bruzzi P, Varesco L.
- Public Health Genomics. [2015 Jul;]18(4):225-32. doi: 10.1159/000431352. Epub 2015 Jun 24.
- PMID: 26111740
- PubMed abstract
- Source abstract
-
- Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.
- Douma KF, Meiser B, Kirk J, Mitchell G, Saunders C, Rahman B, Sousa MS, Barlow-Stewart K, Gleeson M, Tucker K.
- Fam Cancer. 2015 Jun;14(2):265-72. doi: 10.1007/s10689-014-9770-z.
- PMID: 25391616
- PubMed abstract
- Source abstract
-
- The sooner the better: Genetic testing following ovarian cancer diagnosis.
- Fox E, McCuaig J, Demsky R, Shuman C, Chitayat D, Maganti M, Murphy J, Rosen B, Ferguson S, Randall Armel S.
- Gynecol Oncol. 2015 Jun;137(3):423-9. doi: 10.1016/j.ygyno.2015.03.057. Epub 2015 Apr 11.
- PMID: 25868966
- PubMed abstract
- Source abstract
-
- Association of family risk and lifestyle/comorbidities in ovarian cancer patients.
- Teixeira N, Folgueira MA, Maistro S, Encinas G, Bock GH, Diz Mdel P.
- Rev Assoc Med Bras. 2015 May-Jun;61(3):234-9. doi: 10.1590/1806-9282.61.03.234.
- PMID: 26248245
- PubMed abstract
- Source abstract
-
- Feelings of Women With Strong Family Histories Who Subsequent to Their Breast Cancer Diagnosis Tested BRCA Positive.
- Joseph M, Rab F, Panabaker K, Nisker J.
- Int J Gynecol Cancer. 2015 May;25(4):584-92. doi: 10.1097/IGC.0000000000000403.
- PMID: 25675043
- PubMed abstract
- Source abstract
-
- Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing.
- Ratajska M, Krygier M, Stukan M, Kuźniacka A, Koczkowska M, Dudziak M, Śniadecki M, Dębniak J, Wydra D, Brozek I, Biernat W, Borg A, Limon J, Wasąg B.
- J Appl Genet. 2015 May;56(2):193-8. doi: 10.1007/s13353-014-0254-5. Epub 2014 Nov 1.
- PMID: 25366421
- PubMed abstract
-
- Genetic evaluation based on family history and Her2 status correctly identifies TP53 mutations in very early onset breast cancer cases.
- Fostira F, Konstantopoulou I, Mavroudis D, Tryfonopoulos D, Yannoukakos D, Voutsinas GE.
- Clin Genet. 2015 Apr;87(4):383-7. doi: 10.1111/cge.12397. Epub 2014 Apr 29.
- PMID: 24702488
- PubMed abstract
- Source abstract
-
- [Recommendation for genetic testing in patients suffering from gynecological malignancy].
- Zikán M.
- Ceska Gynekol. 2015 Spring;80(2):97-103.
- PMID: 25944599
- PubMed abstract
- Source abstract
-
- Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
- Saam J, Moyes K, Landon M, Williams K, Kaldate RR, Arnell C, Wenstrup R.
- Oncology. [2015 Mar;]88(4):226-33. doi: 10.1159/000368836. Epub 2014 Dec 11.
- PMID: 25503195
- PubMed abstract
- Source abstract
-
- A primary care audit of familial risk in patients with a personal history of breast cancer.
- Nathan P, Ahluwalia A, Chorley W.
- Fam Cancer. 2014 Dec;13(4):591-4. doi: 10.1007/s10689-014-9737-0.
- PMID: 25096803
- PubMed abstract
- Source abstract
-
- From observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivors.
- Vadaparampil ST, Malo TL, Nam KM, Nelson A, de la Cruz CZ, Quinn GP.
- J Cancer Educ. 2014 Dec;29(4):709-19. doi: 10.1007/s13187-014-0643-9.
- PMID: 24706196
- PubMed abstract
- Source abstract
-
- Clinical application of micronucleus test: a case-control study on the prediction of breast cancer risk/susceptibility.
- Bolognesi C, Bruzzi P, Gismondi V, Volpi S, Viassolo V, Pedemonte S, Varesco L.
- PLoS One. 2014 Nov 21;9(11):e112354. doi: 10.1371/journal.pone.0112354. eCollection 2014.
- PMID: 25415331
- PubMed abstract
-
- Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service Perspective.
- Dyer M, Vereecken W, Worrall J, George A, Rahman N.
- Value Health. 2014 Nov;17(7):A643-4. doi: 10.1016/j.jval.2014.08.2327. Epub 2014 Oct 26.
- PMID: 27202307
- PubMed abstract
- Source abstract
-
- Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients.
- Ehlken B, Driedger J, Hofmann-Xu L, Paulus G, Berger K, de Moor C, Schroeder C, Clune J, Tyczynski J.
- Value Health. 2014 Nov;17(7):A663. doi: 10.1016/j.jval.2014.08.2439. Epub 2014 Oct 26.
- PMID: 27202417
- PubMed abstract
- Source abstract
-
- Genetic testing today.
- Euhus D.
- Ann Surg Oncol. 2014 Oct;21(10):3209-15. doi: 10.1245/s10434-014-3906-0. Epub 2014 Jul 17.
- PMID: 25029991
- PubMed abstract
- Source abstract
-
- One Case of a BRCA1 Germ Line Mutation Ovarian Carcinoma Patient Based on Abnormal Immunohistochemistry Finding.
- Kim HJ, Park JM, Lee HW, Lee EH, Kim MK.
- Korean J Pathol. 2014 Oct;48(5):379-81. doi: 10.4132/KoreanJPathol.2014.48.5.379. Epub 2014 Oct 27.
- PMID: 25366075
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
- Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.
- Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.
- PMID: 25025451
- PubMed abstract
- Source abstract
-
- Preoperative genetic testing affects surgical decision making in breast cancer patients.
- Lokich E, Stuckey A, Raker C, Wilbur JS, Laprise J, Gass J.
- Gynecol Oncol. 2014 Aug;134(2):326-30. doi: 10.1016/j.ygyno.2014.05.028. Epub 2014 Jun 5.
- PMID: 24910453
- PubMed abstract
- Source abstract
-
- Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast.
- Valente AL, Rummel S, Shriver CD, Ellsworth RE.
- Hered Cancer Clin Pract. 2014 Jul 19;12(1):17. doi: 10.1186/1897-4287-12-17. eCollection 2014.
- PMID: 25067988
- PubMed abstract
-
- Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system.
- Petzel SV, Vogel RI, McNiel J, Leininger A, Argenta PA, Geller MA.
- Int J Gynecol Cancer. 2014 Jul;24(6):1003-9. doi: 10.1097/IGC.0000000000000148.
- PMID: 24887442
- PubMed abstract
- Source abstract
-
- Family history of cancer associated with breast tumor clinicopathological features.
- Ricks LJ, Ewing A, Thompson N, Harrison B, Wilson B, Richardson F, Carter-Nolan P, Spencer C, Laiyemo A, Williams C.
- J Community Genet. 2014 Jul;5(3):233-40. doi: 10.1007/s12687-013-0180-y. Epub 2014 Jan 15.
- PMID: 24424917
- PubMed abstract
- Source abstract
-
- Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.
- Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, Jensen RA, Fabian CJ, Godwin AK.
- Breast Cancer Res Treat. 2014 Jun;145(3):707-14. doi: 10.1007/s10549-014-2980-0. Epub 2014 May 7.
- PMID: 24807107
- PubMed abstract
- Source abstract
-
- Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.
- Baars JE, Bleiker EM, van Riel E, Rodenhuis CC, Velthuizen ME, Schlich KJ, Ausems MG.
- Clin Genet. 2014 Jun;85(6):524-31. doi: 10.1111/cge.12335. Epub 2014 Feb 4.
- PMID: 24372530
- PubMed abstract
- Source abstract
-
- Genetic Susceptibility to Triple‐Negative Breast Cancers.
- Michelle W Wong‐Brown, Rodney J Scott.
- eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net ; 2014 May; doi: 10.1002/9780470015902.a0025352.
-
- Underestimation of Risk of a BRCA1 or BRCA2 Mutation in Women With High-Grade Serous Ovarian Cancer by BRCAPRO: A Multi-Institution Study.
- Daniels MS, Babb SA, King RH, Urbauer DL, Batte BA, Brandt AC, Amos CI, Buchanan AH, Mutch DG, Lu KH.
- J Clin Oncol. 2014 Apr 20;32(12):1249-55. doi: 10.1200/JCO.2013.50.6055. Epub 2014 Mar 17.
- PMID: 24638001
- PubMed abstract
- Source abstract
Comment/Letter:
Misreported family histories and underestimation of risk.
- PMID: 25199751
- PubMed abstract
- Free Full Text
Comment/Letter:
Reply to D. Braun et al.
- PMID: 25199758
- PubMed abstract
- Free Full Text
-
- Ovarian Cancer 101 for the Newly Diagnosed.
- Ilana Cass.
- FORCE. Be Empowered Webinars. 2014 Apr 11.
- Webinar
- Free video
-
- Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.
- Ayme A, Viassolo V, Rapiti E, Fioretta G, Schubert H, Bouchardy C, Chappuis PO, Benhamou S.
- Breast Cancer Res Treat. 2014 Apr;144(2):379-89. doi: 10.1007/s10549-014-2864-3. Epub 2014 Feb 12.
- PMID: 24519389
- PubMed abstract
- Source abstract
-
- Association Between IHC and MSI Testing to Identify Mismatch Repair-Deficient Patients with Ovarian Cancer.
- Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T.
- Genet Test Mol Biomarkers. 2014 Apr;18(4):229-35. doi: 10.1089/gtmb.2013.0393. Epub 2014 Mar 4.
- PMID: 24592941
- PubMed abstract
- Source abstract
-
- Threshold for genetic testing in women with breast cancer needs to be determined.
- Basu NN, Barr L, Evans DG, Ross GL.
- BMJ. 2014 Mar 6;348:g1863. doi: 10.1136/bmj.g1863.
- PMID: 24603573
- PubMed abstract
- Source abstract
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
- PMID: 24519767
- PubMed abstract
- Free Full Text
-
- Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC).
- Andrés R, Pajares I, Balmaña J, Llort G, Ramón Y Cajal T, Chirivella I, Aguirre E, Robles L, Lastra E, Pérez-Segura P, Bosch N, Yagüe C, Lerma E, Godino J, Miramar MD, Moros M, Astier P, Saez B, Vidal MJ, Arcusa A, Ramón Y Cajal S, Calvo MT, Tres A.
- Clin Transl Oncol. 2014 Mar;16(3):280-4. doi: 10.1007/s12094-013-1070-9. Epub 2013 Aug 27.
- PMID: 23982851
- PubMed abstract
- Source abstract
-
- Routine testing for women with ovarian cancer.
- Arie S.
- BMJ. 2014 Feb 26;348:g1200. doi: 10.1136/bmj.g1200.
- PMID: 24574473
- PubMed abstract
- Source abstract
-
- Germline CDH1 mutations in bilateral lobular carcinoma in situ.
- Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ.
- Br J Cancer. 2014 Feb 18;110(4):1053-7. doi: 10.1038/bjc.2013.792. Epub 2013 Dec 24.
- PMID: 24366306
- PubMed abstract
- Source abstract
-
- London hospital widens access to genetic tests for ovarian cancer.
- Arie S.
- BMJ. 2014 Jan 28;348:g1179. doi: 10.1136/bmj.g1179.
- PMID: 24474303
- PubMed abstract
- Source abstract
-
- New genetic testing pathway for cancer patients.
- Philippa Brice.
- PHG Foundation, 2014 Jan 24.
- News
- Free Full Text
-
- Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.
- Tun N, Villani G, Ong K, Yoe L, Bo Z.
- Clin Genet. 2014 Jan;85(1):43-8. doi: 10.1111/cge.12270. Epub 2013 Oct 3.
- PMID: 24000781
- PubMed abstract
- Source abstract
-
- [Morphologically qnd immunohistochemically based screening criteria for selection of patients with possible mutation of BRCA1 gene in primary ovarian cancer].
- Popovska S, Ivanov I, Dineva T, Jordanov A, Kovacheva K, Kamburova Z, Tomov S, Ivanova V, Boneva I, Mateva S.
- Akush Ginekol (Sofiia). 2014;53(4):21-8.
- PMID: 25510067
- PubMed abstract
-
- A Paternally Inherited BRCA1 Mutation Associated with an Unusual Aggressive Clinical Phenotype.
- Fostira F, Tsoukalas N, Konstantopoulou I, Georgoulias V, Christophyllakis C, Yannoukakos D.
- Case Rep Genet. 2014;2014:875029. doi: 10.1155/2014/875029. Epub 2014 Feb 10.
- PMID: 24660075
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
-
- Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.
- Heitzer E, Lax S, Lafer I, Müller SM, Pristauz G, Ulz P, Jahn S, Högenauer C, Petru E, Speicher MR, Geigl JB.
- BMC Med Genet. 2013 Dec 29;14:129. doi: 10.1186/1471-2350-14-129.
- PMID: 24373500
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas.
- Pécuchet N, Popova T, Manié E, Lucchesi C, Battistella A, Vincent-Salomon A, Caux-Moncoutier V, Bollet M, Sigal-Zafrani B, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH.
- Int J Cancer. 2013 Dec 15;133(12):2834-2842. doi: 10.1002/ijc.28315. Epub 2013 Jul 10.
- PMID: 23754601
- PubMed abstract
- Source abstract
-
- Evaluation of ultra-deep targeted sequencing for personalized breast cancer care.
- Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA.
- Breast Cancer Res. 2013 Dec 10;15(6):R115. doi: 10.1186/bcr3584.
- PMID: 24326041
- PubMed abstract
-
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer.
- Janatova M, Kleibl Z, Stribrna J, Panczak A, Vesela K, Zimovjanova M, Kleiblova P, Dundr P, Soukupova J, Pohlreich P.
- Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2323-32. doi: 10.1158/1055-9965.EPI-13-0745-T. Epub 2013 Oct 17.
- PMID: 24136930
- PubMed abstract
- Source abstract
-
- Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors.
- Hamann HA, Tiro JA, Sanders JM, Melhado TV, Funk RK, Carpentier MY, Bartholomew LK, Argenbright KE, Vernon SW.
- J Cancer Surviv. 2013 Dec;7(4):624-9. doi: 10.1007/s11764-013-0301-y. Epub 2013 Aug 23.
- PMID: 23975610
- PubMed abstract
- Source abstract
-
- Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.
- Francken AB, Schouten PC, Bleiker EM, Linn SC, Rutgers EJ.
- Breast. 2013 Oct;22(5):561-8. doi: 10.1016/j.breast.2013.07.045. Epub 2013 Aug 21.
- PMID: 23972475
- PubMed abstract
- Source abstract
-
- [Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases].
- Badora A, Kaleta B, Nowara E, Sikora-Jopek M, Budryk M, Smok-Ragankiewicz A.
- Ginekol Pol. 2013 Oct;84(10):892-6.
- PMID: 24273914
- PubMed abstract
- Source abstract
- Case report, [Article in Polish]
- Free Full Text
-
- Added value of family history in counseling about risk of BRCA1/2 mutation in early-onset epithelial ovarian cancer.
- Arts-de Jong M, Manders CM, Hoogerbrugge N, Ligtenberg MJ, Massuger LF, de Hullu JA, Spruijt L.
- Int J Gynecol Cancer. 2013 Oct;23(8):1406-10. doi: 10.1097/IGC.0b013e3182a1cf71.
- PMID: 23975082
- PubMed abstract
-
- Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
- Petzel SV, Vogel RI, Bensend T, Leininger A, Argenta PA, Geller MA.
- J Genet Couns. 2013 Oct;22(5):662-73. doi: 10.1007/s10897-013-9598-y. Epub 2013 May 16.
- PMID: 23677535
- PubMed abstract
- Source abstract
-
- Calls for genetic screening of ovarian cancer patients.
- Philippa Brice.
- PHG Foundation. 2013 Sep 18.
- News
- Free Full Text
-
- Charity calls for routine BRCA testing of ovarian cancer patients.
- Wise J.
- BMJ. 2013 Sep 17;347:f5664. doi: 10.1136/bmj.f5664.
- PMID: 24046291
- PubMed abstract
- Source abstract
-
- [Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries].
- Menkiszak J, Chudecka-Głaz A, Gronwald J, Bedner R, Cymbaluk-Płoska A, Wezowska M, Zielińska D, Rzepka-Górska I.
- Ginekol Pol. 2013 Sep;84(9):758-64.
- PMID: 24191513
- PubMed abstract
- Source abstract
- [Article in Polish]
- Free Full Text
-
- Keeping it simple: Genetics referrals for all invasive serous ovarian cancers.
- Demsky R, McCuaig J, Maganti M, Murphy KJ, Rosen B, Armel SR.
- Gynecol Oncol. 2013 Aug;130(2):329-33. doi: 10.1016/j.ygyno.2013.05.003. Epub 2013 May 22.
- PMID: 23707676
- PubMed abstract
- Source abstract
-
- Occult cancer: suspected breast and BRCA gene mutations.
- Mollie L. Hutton, Nicoleta C. Voian, Carolyn D. Farrell.
- Community Oncology. 10(7):202-8. 2013 Jul.
- Case report
- Free Full Text (PDF)
-
- Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.
- Novetsky AP, Smith K, Babb SA, Jeffe DB, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I.
- Int J Gynecol Cancer. 2013 Jul;23(6):1016-21. doi: 10.1097/IGC.0b013e3182994365.
- PMID: 23748176
- PubMed abstract
Comments on NSGC Discussion Forum Cancer SIG
-
- BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.
- Berzina D, Nakazawa-Miklasevica M, Zestkova J, Aksenoka K, Irmejs A, Gardovskis A, Kalniete D, Gardovskis J, Miklasevics E.
- BMC Med Genet. 2013 Jun 14;14:61. doi: 10.1186/1471-2350-14-61.
- PMID: 23767878
- PubMed abstract
-
- Acceptance of genetic counseling and testing in a hospital-based series of patients with gynecological cancer.
- Dekker N, van Dorst EB, van der Luijt RB, van Gijn ME, van Tuil M, Offerhaus JA, Ausems MG.
- J Genet Couns. 2013 Jun;22(3):345-57. doi: 10.1007/s10897-012-9553-3. Epub 2012 Nov 30.
- PMID: 23192360
- PubMed abstract
- Source abstract
-
- Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
- Hassanein M, Huiart L, Bourdon V, Rabayrol L, Geneix J, Nogues C, Peyrat JP, Gesta P, Meynard P, Dreyfus H, Petrot D, Lidereau R, Noguchi T, Eisinger F, Extra JM, Viens P, Jacquemier J, Sobol H.
- Pathobiology. [2013 Jun;]80(5):219-27. doi: 10.1159/000339432. Epub 2013 Apr 23.
- PMID: 23614934
- PubMed abstract
-
- Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
- Larsen MJ, Kruse TA, Tan Q, Lænkholm AV, Bak M, Lykkesfeldt AE, Sørensen KP, Hansen TV, Ejlertsen B, Gerdes AM, Thomassen M.
- PLoS One. 2013 May 21;8(5):e64268. doi: 10.1371/journal.pone.0064268. Print 2013.
- PMID: 23704984
- PubMed abstract
-
- A young woman with bilateral breast cancer: identifying a genetic cause and implications for management.
- de Bruin MA, Ford JM, Kurian AW.
- J Natl Compr Canc Netw. 2013 May 1;11(5):512-7.
- PMID: 23667202
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
- Gleeson M, Meiser B, Barlow-Stewart K, Trainer AH, Tucker K, Watts KJ, Friedlander M, Kasparian N.
- Oncol Nurs Forum. 2013 May 1;40(3):275-83. doi: 10.1188/13.ONF.40-03AP.
- PMID: 23619104
- PubMed abstract
- Source abstract
-
- Genetic predisposition syndromes and their management.
- Euhus DM, Robinson L.
- Surg Clin North Am. 2013 Apr;93(2):341-62. doi: 10.1016/j.suc.2013.01.005. Epub 2013 Feb 11.
- PMID: 23464690
- PubMed abstract
- Source abstract
-
- Early Onset Breast Cancer in a Registry-based Sample of African-American Women: BRCA Mutation Prevalence, and Other Personal and System-level Clinical Characteristics.
- Pal T, Bonner D, Kim J, Monteiro AN, Kessler L, Royer R, Narod SA, Vadaparampil ST.
- Breast J. 2013 Mar;19(2):189-92. doi: 10.1111/tbj.12083. Epub 2013 Jan 16.
- PMID: 23320992
- PubMed abstract
- Source abstract
Press: Young, Black, Female Breast Cancer Patients Need Genetic Risk Strategies. (Medical News Today)
-
- Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.
- Norquist BM, Pennington KP, Agnew KJ, Harrell MI, Pennil CC, Lee MK, Casadei S, Thornton AM, Garcia RL, Walsh T, Swisher EM.
- Gynecol Oncol. 2013 Mar;128(3):483-7. doi: 10.1016/j.ygyno.2012.12.015. Epub 2012 Dec 19.
- PMID: 23262210
- PubMed abstract
- Source abstract
-
- Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
- Powell CB, Littell R, Hoodfar E, Sinclair F, Pressman A.
- Int J Gynecol Cancer. 2013 Mar;23(3):431-6. doi: 10.1097/IGC.0b013e318280f2b4.
- PMID: 23354368
- PubMed abstract
-
- BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
- Pennington KP, Walsh T, Lee M, Pennil C, Novetsky AP, Agnew KJ, Thornton A, Garcia R, Mutch D, King MC, Goodfellow P, Swisher EM.
- Cancer. 2013 Jan 15;119(2):332-8. doi: 10.1002/cncr.27720. Epub 2012 Jul 18.
- PMID: 22811390
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: BRCA1 loss of expression in Uetrine Serous carcinoma
-
- NICE launches consultation on familial breast cancer guidelines.
- Simon Leese.
- PHG Foundation. 2013 Jan 15.
- News
- Free Full Text
-
- BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
- Garg K, Levine DA, Olvera N, Dao F, Bisogna M, Secord AA, Berchuck A, Cerami E, Schultz N, Soslow RA.
- Am J Surg Pathol. 2013 Jan;37(1):138-46. doi: 10.1097/PAS.0b013e31826cabbd.
- PMID: 23232854
- PubMed abstract
- Source abstract
-
- Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next-generation sequencing.
- Jane E. Churpek, Tom Walsh, Yonglan Zheng, Silvia Casadei, Anne M. Thornton, Ming K. Lee, Matthew Churpek, Dezheng Huo, Cecilia Zvosec, Fang Liu, Qun Niu, Jing Zhang, James Fackenthal, Mary-Claire King, Olufunmilayo I. Olopade.
- J Clin Oncol. 2013;31(Suppl): abstr CRA1501. 2013 ASCO Annual Meeting.